IBDEI0SV ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13537,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,13537,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,13538,0)
 ;;=D56.3^^53^593^184
 ;;^UTILITY(U,$J,358.3,13538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13538,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,13538,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,13538,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,13539,0)
 ;;=D56.9^^53^593^185
 ;;^UTILITY(U,$J,358.3,13539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13539,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,13539,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,13539,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,13540,0)
 ;;=M31.1^^53^593^187
 ;;^UTILITY(U,$J,358.3,13540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13540,1,3,0)
 ;;=3^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,13540,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,13540,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,13541,0)
 ;;=D51.2^^53^593^188
 ;;^UTILITY(U,$J,358.3,13541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13541,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,13541,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,13541,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,13542,0)
 ;;=D05.92^^53^593^35
 ;;^UTILITY(U,$J,358.3,13542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13542,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,13542,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,13542,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,13543,0)
 ;;=D05.91^^53^593^37
 ;;^UTILITY(U,$J,358.3,13543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13543,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,13543,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,13543,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,13544,0)
 ;;=D05.90^^53^593^33
 ;;^UTILITY(U,$J,358.3,13544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13544,1,3,0)
 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
 ;;^UTILITY(U,$J,358.3,13544,1,4,0)
 ;;=4^D05.90
 ;;^UTILITY(U,$J,358.3,13544,2)
 ;;=^5001935
 ;;^UTILITY(U,$J,358.3,13545,0)
 ;;=D51.0^^53^593^189
 ;;^UTILITY(U,$J,358.3,13545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13545,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
 ;;^UTILITY(U,$J,358.3,13545,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,13545,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,13546,0)
 ;;=D51.1^^53^593^190
 ;;^UTILITY(U,$J,358.3,13546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13546,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
 ;;^UTILITY(U,$J,358.3,13546,1,4,0)
 ;;=4^D51.1
 ;;^UTILITY(U,$J,358.3,13546,2)
 ;;=^5002285
 ;;^UTILITY(U,$J,358.3,13547,0)
 ;;=D51.9^^53^593^192
 ;;^UTILITY(U,$J,358.3,13547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13547,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,13547,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,13547,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,13548,0)
 ;;=D68.0^^53^593^194
 ;;^UTILITY(U,$J,358.3,13548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13548,1,3,0)
 ;;=3^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,13548,1,4,0)
 ;;=4^D68.0
 ;;^UTILITY(U,$J,358.3,13548,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,13549,0)
 ;;=C88.0^^53^593^195
 ;;^UTILITY(U,$J,358.3,13549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13549,1,3,0)
 ;;=3^Waldenstrom Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,13549,1,4,0)
 ;;=4^C88.0
 ;;^UTILITY(U,$J,358.3,13549,2)
 ;;=^5001748
 ;;^UTILITY(U,$J,358.3,13550,0)
 ;;=C91.02^^53^593^3
 ;;^UTILITY(U,$J,358.3,13550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13550,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,In Relapse
